To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

PHASE3CompletedINTERVENTIONAL
Enrollment

418

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

April 30, 2005

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Ciclesonide

200µg Ciclesonide versus Placebo

DRUG

Placebo

placebo

Trial Locations (23)

20850

Altana/Nycomed, Rockville

27103

Altana/Nycomed, Winston-Salem

27607

Altana/Nycomed, Raleigh

33458

Altana/Nycomed, Jupiter

43560

Altana/Nycomed, Sylvania

55402

Altana/Nycomed, Minneapolis

59804

Altana/Nycomed, Missoula

63141

Altana/Nycomed, St Louis

76132

Altana/Nycomed, Fort Worth

77084

Altana/Nycomed, Houston

80206

Altana/Nycomed, Denver

80230

Altana/Nycomed, Denver

80907

Altana/Nycomed, Colorado Springs

90025

Altana/Nycomed, Los Angeles

90806

Altana/Nycomed, Long Beach

92123

Altana/Nycomed, San Diego

92691

Altana/Nycomed, Mission Viejo

92924

Altana/Nycomed, Encinitas

95117

Altana/Nycomed, San Jose

02747

Altana/Nycomed, North Dartmouth

08724

Altana/Nycomed, Brick

08558

Altana/Nycomed, Skillman

53792-9988

Altana/Nycomed, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY